Expedition Therapeutics

AirNexis Therapeutics

This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.

Elevation Pharmaceuticals

This biopharmaceutical company develops inhaled aerosol therapies for patients with chronic obstructive pulmonary disease to improve lung function and reduce treatment burden.

Breath Therapeutics

This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.

EpiEndo Pharmaceuticals

This biopharmaceutical company develops oral, non-antibiotic therapies to treat chronic respiratory diseases, such as COPD, for patients requiring anti-inflammatory and barrier-strengthening treatments.

Apogee Therapeutics

This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.

Aer Therapeutics

This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.

Enterprise Therapeutics

This biopharmaceutical company develops novel muco-regulatory therapies for patients with respiratory diseases including cystic fibrosis, asthma and chronic obstructive pulmonary disease.